Gaps in information, support among women who gain weight during breast cancer treatment
the ONA take:
There may be gaps in information and support provision after diagnosis in the areas of weight management, nutrition-related side effects of chemotherapy, and healthy living among women undergoing chemotherapy for breast cancer, a study published in the journal Supportive Care in Cancer had shown.
For the study, researchers sought to explore the experiences, dietary information, and support needs of women who gain weight during chemotherapy treatment for breast cancer as overweight and obesity are associated with reduced self-esteem, other co-morbidities, and an increased risk of cancer recurrence.
Researchers observed three key themes when interviewing 17 women who gained weight: 1) undesirable impacts of cancer treatment on diet and physical activity, 2) surprise and concern related to weight and diet changes, and 3) insufficient dietary education and support.
The authors conclude that "models of dietetic practice and the provision of tailored dietary information should be explored."
There may be gaps in information and support provision after diagnosis for breast cancer.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|